TCG Opportunity III GP, LLC, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 300 shares at $4.98 ($1K) on 2022-12-12, disclosed to the SEC on 2022-12-14.
Recurring purchase ($1k) by 10% Owner following this insider's established cadence. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| NGM | BUY | 2023-02-01 | $921K | — | Filing → |
| NGM | BUY | 2023-01-23 | $191K | — | Filing → |
| NGM | BUY | 2023-01-17 | $27K | — | Filing → |